Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Mediterranean Journal of Rheumatology|June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort StudyDaniele Lini, Matteo Colina, Romina Andracco, et al.Therapeutic Advances in Musculoskeletal Disease|July 16, 2025
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)Martina Orlandi, Dilia Giuggioli, Clodoveo Ferri, et al.Journal of Scleroderma and Related Disorders|February 9, 2024
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) RegistryValeria Riccieri, Greta Pellegrino, Edoardo Cipolletta, et al.Journal of Autoimmunity|November 15, 2025
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for RheumatologyAntonio Tonutti, Francesca Motta, Gianluigi Bajocchi, et al.Rheumatology Advances in Practice|September 22, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre studyAndrea Becciolini, Antonio Marchesoni, Simone Parisi, et al.RMD Open|March 3, 2023
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for RheumatologyRossella De Angelis, Clodoveo Ferri, Dilia Giuggioli, et al.The Journal of Rheumatology|January 15, 2025
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR RegistryFabio Cacciapaglia, Rossella De Angelis, Clodoveo Ferri, et al.Journal of Translational Autoimmunity|October 19, 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phaseClodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.Rheumatology (Oxford, England)|September 5, 2025
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registryFrancesco Bonomi, Cosimo Bruni, Silvia Peretti, et al.The Journal of Rheumatology|November 16, 2021
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for RheumatologyRossella De Angelis, Dilia Giuggioli, Gianluigi Bajocchi, et al.Pageof 8